Wednesday, November 20, 2019

Predicting treatment outcome for leishmaniasis

For patients with cutaneous leishmaniasis, a skin infection transmitted by a sand fly that can in some cases lead to painful and disfiguring ulcers, treatment can be grueling. The first-line therapy offered to many requires daily infusions of the metalloid pentavalent antimony for three weeks, and half of patients don’t respond to just one round of therapy. Some fail two or even three courses. And the side effects of therapy can range from mere irritation to far more serious conditions.

From http://besthealthnews.com/2019/11/predicting-treatment-outcome-for-leishmaniasis/?utm_source=rss&utm_medium=rss&utm_campaign=predicting-treatment-outcome-for-leishmaniasis

from
https://healthnews010.wordpress.com/2019/11/21/predicting-treatment-outcome-for-leishmaniasis/

From https://jamesjohnson10.blogspot.com/2019/11/predicting-treatment-outcome-for.html



from
https://jamesjohnson10.wordpress.com/2019/11/21/predicting-treatment-outcome-for-leishmaniasis/

No comments:

Post a Comment